These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16362799)

  • 1. Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C.
    Tanaka H; Miyano M; Ueda H; Fukui K; Ichinose M
    Clin Exp Med; 2005 Dec; 5(4):190-5. PubMed ID: 16362799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of the spleen to the lipid metabolism in plasma and red cells. On hereditary spherocytosis and hereditary high red cell membrane phosphatidylcholine hemolytic anemia].
    Sugihara T; Otsuka A; Yawata Y
    Rinsho Ketsueki; 1989 Aug; 30(8):1248-55. PubMed ID: 2601042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
    Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
    J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability.
    Seki R; Okamura T; Ide T; Kage M; Sata M; Uyesaka N; Maruyama T
    J Physiol Sci; 2007 Feb; 57(1):43-9. PubMed ID: 17204208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.
    Hino K; Murakami Y; Nagai A; Kitase A; Hara Y; Furutani T; Ren F; Yamaguchi Y; Yutoku K; Yamashita S; Okuda M; Okita M; Okita K
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1269-75. PubMed ID: 16872308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia.
    Grattagliano I; Russmann S; Palmieri VO; Portincasa P; Palasciano G; Lauterburg BH
    Clin Pharmacol Ther; 2005 Oct; 78(4):422-32. PubMed ID: 16198661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin.
    Lin CC; Yin MC
    Clin Nutr; 2009 Feb; 28(1):34-8. PubMed ID: 19042060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
    Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
    J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations of erythrocyte lipid pattern and of some membrane related functions as a consequence of plasma lipid disorder in diabetes mellitus.
    Cignarelli M; Blonda M; Cospite MR; Damato A; Nardelli G; Giorgino R
    Diabete Metab; 1983 Dec; 9(4):272-6. PubMed ID: 6667763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 13. The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability.
    Martínez M; Vayá A; Gil L; Martí R; Dalmau J; Aznar J
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):259-63. PubMed ID: 9741666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced haemolytic anaemia in hepatitis C.
    Al-Ansari M; Weilert F; Dickson G
    N Z Med J; 2008 Jul; 121(1278):78-81. PubMed ID: 18670477
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin.
    Milazzo L; Biasin M; Gatti N; Piacentini L; Niero F; Zanone Poma B; Galli M; Moroni M; Clerici M; Riva A
    Am J Gastroenterol; 2006 Feb; 101(2):399-402. PubMed ID: 16454849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum levels of vascular endothelial growth factor in chronic hepatitis C patients treated with interferon alpha and ribavirin].
    Janczewska-Kazek E; Marek B; Pisula A; Kajdaniuk D; Witor A; Magiera M; Witor A
    Wiad Lek; 2007; 60(3-4):120-3. PubMed ID: 17726862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitiligo and alopecia in patients with chronic hepatitis C treated with alpha interferon associated or not with ribavirin].
    Primo J; Merino C; Gómez Belda AB
    Gastroenterol Hepatol; 2000; 23(7):362-3. PubMed ID: 11002542
    [No Abstract]   [Full Text] [Related]  

  • 19. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
    Yu ML; Dai CY; Lee LP; Hou NJ; Hsieh MY; Huang JF; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
    Liver Int; 2006 Dec; 26(10):1187-95. PubMed ID: 17105583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The erythrocyte membrane structure in patients with mixed hyperlipidemia].
    Broncel M; Balcerak M; Bała A; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
    Wiad Lek; 2007; 60(1-2):4-9. PubMed ID: 17607961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.